Drugs in Rheumatic Disease During Pregnancy

Prescribing in Pregnancy: Fourth Edition

Volumn , Issue , 2008, Pages 98-113

  Gayed, Mary ^a   Gordon, Caroline ^b  

^a CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Analgesia; Drugs; Musculoskeletal pain; Pregnancy; Rheumatic disease

Indexed keywords

EID: 84873991618     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470696293.ch7     Document Type: Chapter

References (48)

1. Gordon C. Pregnancy and autoimmune diseases. Best Pract Res Clin Rheumatol 2004;18(3):359-79.
2. Bonaminio PN, de Regnier R, Chang E, Day N, Manzi S, Ramsey-Goldman R. Minor physical anomalies are not increased in the offspring of mothers with systemic lupus erythematosus. Ann Rheum Dis 2006;65(2):246-8.
3. Clowse M, Petri M. Pregnancy and SLE. In: Tsokos G, Gordon C, Smolen J (eds.), Systemic Lupus Erythematosus: A Companion to Rheumatology, 1st edition. Philadelphia: Mosby Elsevier; 2007:449-59.
4. Ostensen M, Khamashta M, Lockshin M, et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 2006;8(3):209.
5. Clowse ME, Magder L, Witter F, Petri M. Hydroxychloroquine in lupus pregnancy. Arthritis Rheum 2006;54(11):3640-7.
6. Costedoat-Chalumeau N, Amoura Z, Aymard G, et al. Evidence of transplacental passage of hydroxychloroquine in humans. Arthritis Rheum 2002;46(4):1123-4.
7. Buchanan NM, Toubi E, Khamashta MA, Lima F, Kerslake S, Hughes GR. Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases. Ann Rheum Dis 1996;55(7):486-8.
8. Costedoat-Chalumeau N, Amoura Z, Duhaut P, et al. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group. Arthritis Rheum 2003;48(11):3207-11.
9. Motta M, Tincani A, Faden D, et al. Follow-up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation. J Perinatol 2005;25(2):86-9.
10. Klinger G, Morad Y, Westall CA, et al. Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases. Lancet 2001;358(9284):813-4.
11. Pierangeli SS, Chen PP, Gonzalez EB. Antiphospholipid antibodies and the antiphospholipid syndrome: an update on treatment and pathogenic mechanisms. Curr Opin Hematol 2006;13(5):366-75.
12. Norgard B, Czeizel AE, Rockenbauer M, Olsen J, Sorensen HT. Population-based case control study of the safety of sulfasalazine use during pregnancy. Aliment Pharmacol Ther 2001;15(4):483-6.
13. Nielsen OH, Andreasson B, Bondesen S, Jarnum S. Pregnancy in ulcerative colitis. Scand J Gastroenterol 1983;18(6):735-42.
14. Jarnerot G, Andersen S, Esbjorner E, Sandstrom B, Brodersen R. Albumin reserve for binding of bilirubin in maternal and cord serum under treatment with sulphasalazine. Scand J Gastroenterol 1981;16(8):1049-55.
15. Zwi LJ, Becroft DM. Intrauterine aplastic anemia and fetal hydrops: a case report. Pediatr Pathol 1986;5(2):199-205.
16. Levi S, Liberman M, Levi AJ, Bjarnason I. Reversible congenital neutropenia associated with maternal sulphasalazine therapy. Eur J Pediatr 1988;148(2):174-5.
17. Branski D, Kerem E, Gross-Kieselstein E, Hurvitz H, Litt R, Abrahamov A. Bloody diarrhea-a possible complication of sulfasalazine transferred through human breast milk. J Pediatr Gastroenterol Nutr 1986;5(2):316-7.
18. Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 2000;343(22):1608-14.
19. Janssen NM, Genta MS. The effects of immunosuppressive and antiinflammatory medications on fertility, pregnancy, and lactation. Arch Intern Med 2000;160(5):610-9.
20. Richards AJ, Henderson W. Transfer of gold from mother to foetus. Lancet 1977;1:99.
21. Cohen DL, Orzel J, Taylor A. Infants of mothers receiving gold therapy. Arthritis Rheum 1981;24(1):104-5.
22. Ostensen M, Husby G. Antirheumatic drug treatment during pregnancy and lactation. Scand J Rheumatol 1985;14(1):1-7.
23. Ostensen M, Skavdal K, Myklebust G, Tomassen Y, Aarbakke J. Excretion of gold into human breast milk. Eur J Clin Pharmacol 1986;31(2):251-2.
24. Temprano KK, Bandlamudi R, Moore TL. Antirheumatic drugs in pregnancy and lactation. Semin Arthritis Rheum 2005;35(2):112-21.
25. Chakravarty EF, Sanchez-Yamamoto D, Bush TM. The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes. J Rheumatol 2003;30(2):241-6.
26. Miehle W. Current aspects of D-penicillamine and pregnancy. Z Rheumatol 1988;47(Suppl 1):20-3.
27. Scheinberg IH, Sternlieb I. Pregnancy in penicillamine-treated patients with Wilson's disease. N Engl J Med 1975;293(25):1300-2.
28. Walshe JM. Pregnancy in Wilson's disease. Q J Med 1977;46(181):73-83.
29. Schroder H, Fogh K. Methotrexate and its polyglutamate derivatives in erythrocytes during and after weekly low-dose oral methotrexate therapy of children with acute lymphoblastic leukemia. Cancer Chemother Pharmacol 1988;21(2):145-9.
30. Hausknecht RU. Methotrexate and misoprostol to terminate early pregnancy. N Engl J Med 1995;333(9):537-40.
31. Schleuning M, Clemm C. Chromosomal aberrations in a newborn whose mother received cytotoxic treatment during pregnancy. N Engl J Med 1987;317(26):1666-7.
32. Johns DG, Rutherford LD, Leighton PC, Vogel CL. Secretion of methotrexate into human milk. Am J Obstet Gynecol 1972;112(7):978-80.
33. Armenti VT, Ahlswede KM, Ahlswede BA, Jarrell BE, Moritz MJ, Burke JF. National transplantation pregnancy registry-outcomes of 154 pregnancies in cyclosporine-treated female kidney transplant recipients. Transplantation 1994;57(4):502-6.
34. Hussein MM, Mooij JM, Roujouleh H. Cyclosporine in the treatment of lupus nephritis including two patients treated during pregnancy. Clin Nephrol 1993;40(3):160-3.
35. Moretti M, Sgro M, Johnson D, Sauve R, Woolgar M. Cyclosporin excretion into breast milk. Transplantation 2003;7:3144-6.
36. Polifka JE, Friedman JM. Teratogen update: azathioprine and 6-mercaptopurine. Teratology 2002;65(5):240-61.
37. Scott JR. Fetal growth retardation associated with maternal administration of immunosuppressive drugs. Am J Obstet Gynecol 1977;128(6):668-76.
38. Cote CJ, Meuwissen HJ, Pickering RJ. Effects on the neonate of prednisone and azathioprine administered to the mother during pregnancy. J Pediatr 1974;85(3):324-8.
39. Davison JM, Dellagrammatikas H, Parkin JM. Maternal azathioprine therapy and depressed haemopoiesis in the babies of renal allograft patients. Br J Obstet Gynaecol 1985;92(3):233-9.
40. Hayslett JP, Lynn RI. Effect of pregnancy in patients with lupus nephropathy. Kidney Int 1980;18(2):207-20.
41. Meehan RT, Dorsey JK. Pregnancy among patients with systemic lupus erythematosus receiving immunosuppressive therapy. J Rheumatol 1987;14(2):252-8.
42. Bermas BL, Hill JA. Effects of immunosuppressive drugs during pregnancy. Arthritis Rheum 1995;38(12):1722-32.
43. Lockshin MD. Fertility in systemic lupus erythematosus. In Tsokos G, Gordon C, Smolen J (eds), Systemic Lupus Erythematosus: A Companion to Rheumatology, 1st edition. Philadelphia: Mosby Elsevier; 2007:460-5.
44. Kirshon B, Wasserstrum N, Willis R, Herman GE, McCabe ER. Teratogenic effects of first-trimester cyclophosphamide therapy. Obstet Gynecol 1988;72(3 Pt 2):462-4.
45. Gershenson DM. Menstrual and reproductive function after treatment with combination chemotherapy for malignant ovarian germ cell tumors. J Clin Oncol 1988;6(2):270-5.
46. Clowse ME, Magder L, Petri M. Cyclophosphamide for lupus during pregnancy. Lupus 2005;14(8):593-7.
47. Wiernik PH, Duncan JH. Cyclophosphamide in human milk. Lancet 1971;1(7705):912.
48. Carter JD, Valeriano J, Vasey FB. Tumor necrosis factor-alpha inhibition and VATER association: a causal relationship. J Rheumatol 2006;33(5):1014-7.